EPT Disclosure
April 01 2009 - 6:07AM
UK Regulatory
TIDMTED
RNS Number : 9112P
Seymour Pierce Ltd
01 April 2009
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
+------------------------------------+------------------------------------------------------+
| Name of exempt principal trader | Seymour Pierce Limited |
+------------------------------------+------------------------------------------------------+
| Company dealt in | Tepnel Life Sciences plc |
+------------------------------------+------------------------------------------------------+
| Class of relevant security to | Ordinary 1p Shares |
| which the dealings being disclosed | |
| relate (Note 1) | |
+------------------------------------+------------------------------------------------------+
| Date of dealing | 31.03.09 |
+------------------------------------+------------------------------------------------------+
2. DEALINGS (Note 2)
(a)Purchases and sales
+------------------------------+-----------------------------+-------------------------------+
| Total number of securities | Highest price paid (Note 3) | Lowest price paid (Note 3) |
| purchased | | |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| 20,000 | 0.26750 GBP | 0.26750 GBP |
+------------------------------+-----------------------------+-------------------------------+
+------------------------------+-----------------------------+-------------------------------+
| Total number of securities | Highest price received | Lowest price received (Note |
| sold | (Note 3) | 3) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
(b) Derivatives transactions (other than options)
+-----------------+--------------------+----------------------------+-------------------------+
| Product name, | Long/short (Note | Number of securities (Note | Price per unit (Note 3) |
| e.g. CFD | 4) | 5) | |
+-----------------+--------------------+----------------------------+-------------------------+
| | | | |
+-----------------+--------------------+----------------------------+-------------------------+
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
| Product name, | Writing, | Number of | Exercise | Type, e.g. | Expiry | Option money |
| e.g. call | selling, | securities to | price | American, | date | paid/received |
| option | purchasing, | which the | | European | | per unit |
| | varying etc. | option relates | | etc. | | (Note 3) |
| | | (Note 5) | | | | |
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
| | | | | | | |
+-----------------+--------------+-----------------+----------+------------+---------+---------------+
(ii) Exercising
+------------------------------+-----------------------------+-------------------------------+
| Product name, e.g. call | Number of securities | Exercise price per unit (Note |
| option | | 3) |
| | | |
+------------------------------+-----------------------------+-------------------------------+
| | | |
+------------------------------+-----------------------------+-------------------------------+
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
+------------------------------------------------------------------------------------------+
| Full details of any agreement, arrangement or understanding between the person |
| disclosing and any other person relating to the voting rights of any relevant securities |
| under any option referred to on this form or relating to the voting rights or future |
| acquisition or disposal of any relevant securities to which any derivative referred to |
| on this form is referenced. If none, this should be stated. |
+------------------------------------------------------------------------------------------+
| |
+------------------------------------------------------------------------------------------+
+---------------------------------------------------+---------------------------------------+
| Date of disclosure | 01.04.09 |
+---------------------------------------------------+---------------------------------------+
| Contact name | Caroline Woodyer |
+---------------------------------------------------+---------------------------------------+
| Telephone number | 020 7107 8056 |
+---------------------------------------------------+---------------------------------------+
| Name of offeree/offeror with which connected | Tepnel Life Sciences |
+---------------------------------------------------+---------------------------------------+
| Nature of connection (Note 6) | Nomad & Broker |
+---------------------------------------------------+---------------------------------------+
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMCKDKKKBKDOQK
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024